A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(10), P. 1330 - 1330
Published: Oct. 19, 2024
Currently,
the
age
structure
of
world
population
is
changing
due
to
declining
birth
rates
and
increasing
life
expectancy.
As
a
result,
physicians
worldwide
have
treat
an
number
age-related
diseases,
which
neurological
disorders
represent
significant
part.
In
this
context,
there
urgent
need
discover
new
therapeutic
approaches
counteract
effects
neurodegeneration
on
human
health,
computational
science
can
be
pivotal
importance
for
more
effective
neurodrug
discovery.
The
knowledge
molecular
receptors
other
biomolecules
involved
in
pathogenesis
facilitates
design
molecules
as
potential
drugs
used
fight
against
diseases
high
social
relevance
such
dementia,
Alzheimer's
disease
(AD)
Parkinson's
(PD),
cite
only
few.
However,
absence
comprehensive
guidelines
regarding
strengths
weaknesses
alternative
creates
fragmented
disconnected
field,
resulting
missed
opportunities
enhance
performance
achieve
successful
applications.
This
review
aims
summarize
some
most
innovative
strategies
based
methods
development.
particular,
recent
applications
state-of-the-art
docking
artificial
intelligence
ligand-
target-based
novel
drug
were
reviewed,
highlighting
crucial
role
silico
context
discovery
neurodegenerative
diseases.
Language: Английский
Effects and mechanisms of water extract of Uraria crinit a on manganese chloride-induced apoptosis in SH-SY5Y cells
Jin–Tung Liang,
No information about this author
Weiwei Yin,
No information about this author
Duanzhuo Li
No information about this author
et al.
CyTA - Journal of Food,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 11, 2025
Language: Английский
Efficacy of Mucuna pruriens (L.) DC. in treating diabetes, Parkinson’s disease, and erectile dysfunction—a review of clinical and preclinical trials
Published: April 23, 2025
Among
the
most
common
medical
problems
experienced
by
older
adults
(over
60
years)
are
diabetes,
Parkinson’s
disease
(PD),
and
erectile
dysfunction
(ED).
The
potential
use
of
Mucuna
pruriens
in
treating
type
2
diabetes
(T2D),
PD,
ED
is
being
investigated.
Literature
searches
were
conducted
using
PubMed,
MEDLINE,
Mendeley
databases
(1990–2023).
Key
words
related
to
pruriens,
EDs
used.
An
analysis
26
preclinical
clinical
trials
suggested
that
may
be
used
treat
ED.
This
study
revealed
a
correlation
between
Parkinson’s,
ED,
with
metabolic
disorders
cause.
pruriens-based
therapeutics
could
positive
source
leva-dopa
(LD)
medications.
It
well
tolerated
beneficial
for
brain
function
overall
health.
Evidence
suggests
it
has
effects
on
libido,
testosterone
levels,
PD.
important
note
PD
linked
multiple
mechanisms.
In
many
(in
humans
animals),
found
effective
at
diabetes.
further
necessary
conduct
additional
scientific
studies
confirm
molecular
mechanisms
biomarkers
link
phytochemicals
Language: Английский
Advances in Understanding Biomarkers and Treating Neurological Diseases -Role of the Cerebellar Dysfunction and Emerging Therapies
Ageing Research Reviews,
Journal Year:
2024,
Volume and Issue:
unknown, P. 102519 - 102519
Published: Sept. 1, 2024
Language: Английский
Exploring Nanocarriers for Boosting Entacapone Bioavailability: A Journey through System Characterization and Assessment of Toxicity and Pharmacological and 2D Permeability Paybacks
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(43), P. 58299 - 58312
Published: Oct. 21, 2024
Catechol-O-methyltransferase
inhibitors
(iCOMT),
such
as
entacapone,
have
been
successfully
employed
to
treat
tremor-related
symptoms
of
Parkinson's
disease.
However,
iCOMT
has
associated
with
a
short
half-life
and
poor
oral
bioavailability.
Nanobased
drug
delivery
systems
often
used
overcome
this
type
setbacks.
Therefore,
entacapone
was
encapsulated
in
PEGylated
poly(lactic-co-glycolic
acid)
(PLGA)-based
nanoparticles
(NPs)
via
nanoprecipitation
process,
well
nanostructured
lipid
carriers
(NLCs)
using
solvent
emulsification/evaporation
method.
Both
nanoformulations
presented
sub-200
nm
populations,
zeta-potential
(ZP)
values
close
-30
mV,
showed
stability
at
different
pHs,
while
maintaining
their
physicochemical
properties
mostly
intact,
presenting
only
change
superficial
charge
(ZP
values),
indicating
interaction.
interaction
mucins,
which
anticipates
good
permeation
bioavailability
for
topical
administration.
No
cytotoxic
effects
were
observed
lyophilized
PLGA
NPs
encapsulating
2-hydroxypropyl-ß-cyclodextrin
(HPβCD)
cryoprotectant
3%
concentration
(HP-PLGA@Ent),
human
hepatocellular
carcinoma
(HepG2),
neuroblastoma
(SH-SY5Y),
or
epithelial
colorectal
adenocarcinoma
(Caco-2)
cell
lines.
Conversely,
NLCs
(W-NLCs@Ent)
on
the
HepG2
line,
likely
due
intracellular
accumulation
storage.
maintained
COMT
inhibition
effect
cells,
3-BTD
probe.
An
increase
permeability
both
monolayer
coculture
models
(Caco-2
Caco-2/HT29-MTX,
respectively)
developed
nanoformulations.
Overall,
work
shows
that
nanocarriers
could
be
stimulating
alternative
solve
setbacks,
since
they
improve
its
still
inhibitory
activity.
Language: Английский
Aquilaria crassna Extract Exerts Neuroprotective Effect against Benzo[a]pyrene-Induced Toxicity in Human SH-SY5Y Cells: An RNA-Seq-Based Transcriptome Analysis
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(16), P. 2727 - 2727
Published: Aug. 16, 2024
Benzo[a]pyrene
(B[a]P)
is
known
to
inhibit
neurodifferentiation
and
induce
neurodegeneration.
Agarwood
or
Aquilaria
crassna
(AC),
a
plant
with
health-promoting
properties,
may
counteract
the
neurotoxic
effects
of
B[a]P
by
promoting
neuronal
growth
survival.
This
study
investigated
protective
effect
AC
leaf
ethanolic
extract
(ACEE)
on
B[a]P-induced
impairment
differentiation.
A
transcriptomic
analysis
identified
canonical
pathway,
biological
network,
differentially
expressed
genes
(DEGs)
that
are
changed
in
response
differentiation
neurogenesis.
Several
genes,
including
CXCR4,
ENPP2,
GAP43,
GFRA2,
NELL2,
NFASC,
NSG2,
NGB,
BASP1,
NEUROD1,
B[a]P-treated
SH-SY5Y
cells
were
up-regulated
after
treatment
ACEE.
Notably,
Western
blot
further
confirmed
ACEE
increased
protein
levels
GAP43
neuroglobin.
led
decreased
phosphorylation
Akt
ERK
cells;
however,
was
able
reverse
these
effects.
Clionasterol
lupenone
Molecular
docking
showed
two
phytochemicals
had
significant
interactions
GDNF
family
receptor
alpha
(GFRA),
retinoid
X
receptors
(RXRs).
In
conclusion,
be
potential
alternative
medicine
for
prevention
impaired
neurodegenerative
diseases.
Language: Английский